SAS Output

26-APR-2018 6:10

BREAST ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 Y 1 Recurrence Score testing 9400 9383 327 0 0 0 0 02/28/2011 439 211
            9383 327 0 0 0 0      
 
    2 Y 2 Chemo and Endocrine Therapy 5000 2547 122 0 0 0 0 02/28/2011    
        3 Endocrine Therapy Alone   2536 121 0 0 0 0      
            5083 243 0 0 0 0      
 
  S1207-Brst,Adj,Endocrine+/-Everolimus 1 Y 1 Blinded drug + Endocrine 1900 785 185 93 49 18 2 09/12/2013 463 242
        2 Blinded drug + Endocrine   791 198 90 44 16 1      
            1576 383 183 93 34 3      
 
  S1222-Brst,Fulv. +/- Ever. +/- Anastr. 1 T 1 Blinded treatment 840 12 0 0 0 0 0 05/15/2014 22 6
        2 Blinded treatment   12 0 0 0 0 0      
        3 Blinded treatment   13 0 0 0 0 0      
            37 0 0 0 0 0      
 
  S1416-Brst, TNBC/BRCA, Cis+/- ABT-888 1 Y 1 Blinded Drug + Cisplatin 333 123 88 41 18 6 0 09/15/2016 279 132
        2 Blinded Drug + Cisplatin   121 88 41 17 6 0      
            244 176 82 35 12 0      
 
  S1418-Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 Y 1 Tissue for PD-L1 testing 1000 205 187 112 62 15 4 01/18/2017 412 188
            205 187 112 62 15 4      
 
    2 Y 2 Observation 1000 92 88 53 30 14 0 01/18/2017    
        3 MK-3475 (Pembrolizumab)   86 80 46 28 6 0      
            178 168 99 58 20 0      
 
Yes A011106-Breast, Neoadj, ALTERNATE study 1 E Total Registrations   56 22 6 3 3 0 04/29/2014 263 123
            56 22 6 3 3 0      
 
  E1Z11-Brst,Genetic Predictors of AIMSS 1 E Total Registrations   150 10 6 2 0 0 08/13/2013 218 80
            150 10 6 2 0 0      
 
No A011202-Breast, Nodal XRT +/- ALND 0 E Total Registrations   169 58 27 14 6 1 03/20/2014 357 189
            169 58 27 14 6 1      
 
    1 E Total Registrations   67 21 10 6 3 0 03/20/2014    
            67 21 10 6 3 0      
 
  A011401-Breast, adj, Stage II/III HER2-, weight loss 1 E Total Registrations   133 104 55 31 9 3 10/05/2016 435 234
            133 104 55 31 9 3      
 
    2 E Total Registrations   117 94 49 29 7 0 10/05/2016    
            117 94 49 29 7 0      
 
  A011502-Brst, Adj, Nodal+&HER2-, Aspirin vs. Placebo 1 E Total Registrations   35 33 16 11 6 4 03/20/2017   219
            35 33 16 11 6 4      
 
  A221405-Breast, ET interruption, Pregnancy Outcomes 1 E Total Registrations   9 9 5 1 0 0 05/08/2017   63
            9 9 5 1 0 0      
 
  B51-Breast, Regional Nodal XRT 1 E Total Registrations   25 13 4 0 0 0 06/13/2014 421 223
            25 13 4 0 0 0      
 
  B55-Brst, Adj Olaparib for BRCA,TNBC 1 E Total Registrations   57 19 12 5 2 0 12/15/2014 425 186
            57 19 12 5 2 0      
 
    2 E Total Registrations   24 9 4 1 1 0 12/15/2014    
            24 9 4 1 1 0      
 
  E2112-Brst,Adv,Exemestane+/-Entinostat 1 E Total Registrations   46 15 6 2 0 0 04/01/2015 296 165
            46 15 6 2 0 0      
 
  EA1131-Brst, TNBC, Post-op Chemo vs Obs 0 E Total Registrations   18 10 4 3 2 0 11/12/2015 318 136
            18 10 4 3 2 0      
 
    1 P Total Registrations   9 8 2 1 1 0 11/12/2015    
            9 8 2 1 1 0      
 
  EA1151-Brst, Tomosynthesis Mammographic Screening 1 E Total Registrations   60 60 60 60 30 5 01/30/2018   51
            60 60 60 60 30 5      
 
  NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA 1 E Total Registrations   1 1 0 0 0 0 09/22/2017   28
            1 1 0 0 0 0      
 
  NRGBR003-Brst,Adj,TNBC,AC -> WP +/- Carbo 1 E Total Registrations   51 23 7 3 0 0 10/16/2015 435 211
            51 23 7 3 0 0